Therapy News and Research

RSS

Ups and downs of incorporating new treatment to reduce oxaliplatin-induced neuropathy

In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.

21 Sep 2015

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.

21 Sep 2015

Report: Birth control pills cause significant increase in stroke risk

Birth control pills cause a small but significant increase in the risk of the most common type of stroke, according to a comprehensive report in the journal MedLink Neurology.

21 Sep 2015

Enhanced pharmacist care improves outcomes in patients with high blood pressure

Patients with high blood pressure are benefiting from the expanded role played by pharmacists in Alberta, according to a new study from the University of Alberta's Faculty of Medicine & Dentistry.

21 Sep 2015

Adolescents with bulimia nervosa recover faster when parents involved in treatment

Involving parents in the treatment of adolescents with bulimia nervosa is more effective than treating the patient individually, according to a study led by Daniel Le Grange, PhD, Benioff UCSF Professor in children's health in the departments of psychiatry and pediatrics at UCSF Benioff Children's Hospital San Francisco, and James Lock, MD, PhD, professor of psychiatry at Stanford University School of Medicine.

21 Sep 2015

Ultrasonic attenuation could be early indicator of preterm-birth risk

Ultrasonic attenuation -- an ultrasound's gradual loss of energy as the sound waves circulate through tissue -- could be an early indicator of whether a pregnant woman is at risk for delivering prematurely, according to a new study at the University of Illinois at Chicago College of Nursing.

19 Sep 2015

Manchester researchers reveal why ER+ breast cancer women develop resistance to hormone therapy

University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.

18 Sep 2015

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.

18 Sep 2015

Study confirms pathogenic role of beta amyloid in dementia as seen in AD and Down syndrome

More than five million Americans are living with Alzheimer's disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid.

18 Sep 2015

Quethera receives seed investment funding to develop gene therapy for glaucoma

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven’s Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.

18 Sep 2015

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.

18 Sep 2015

CEVEC partners with Généthon to develop lentivirus packaging cell lines based on its CAP GT technology

CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Généthon (Evry, France) for the development and exploitation of lentivirus packaging cell lines based on CEVEC’s proprietary CAP GT technology.

18 Sep 2015

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 will highlight innovations and controversies in the field, guaranteeing great stories on topics relevant to the press.

18 Sep 2015

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond — and which should switch to another kind of treatment.

18 Sep 2015

Tolerability benefits with sunitinib schedule switch

Switching sunitinib treatment from a 4/2 to a modified 2/1 schedule can improve the tolerability profile for patients with metastatic renal cell carcinoma, say researchers.

17 Sep 2015

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.

17 Sep 2015

Public lecture discusses the future beyond antibiotics

Pioneering research into bacteriophage therapy as an alternative to antibiotics will be discussed at this year’s Frank May Prize Lecture on Monday 21 September from 5.30 – 6.30pm in the Frank and Katherine May Lecture Theatre, Henry Wellcome Building at the University of Leicester.

17 Sep 2015

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.

16 Sep 2015

World Scientific's latest book to be launched on Stem Cell Awareness Day

While the world knows the $3 billion California Institute for Regenerative Medicine sprang from the citizen's initiative, Proposition 71, few people know the struggle required, nor what happened after California said "Yes!"

16 Sep 2015

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.

16 Sep 2015

Therapy News and Research

Ups and downs of incorporating new treatment to reduce oxaliplatin-induced neuropathy

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Report: Birth control pills cause significant increase in stroke risk

Enhanced pharmacist care improves outcomes in patients with high blood pressure

Adolescents with bulimia nervosa recover faster when parents involved in treatment

Ultrasonic attenuation could be early indicator of preterm-birth risk

Manchester researchers reveal why ER+ breast cancer women develop resistance to hormone therapy

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Study confirms pathogenic role of beta amyloid in dementia as seen in AD and Down syndrome

Quethera receives seed investment funding to develop gene therapy for glaucoma

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

CEVEC partners with Généthon to develop lentivirus packaging cell lines based on its CAP GT technology

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

Tolerability benefits with sunitinib schedule switch

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

Public lecture discusses the future beyond antibiotics

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

World Scientific's latest book to be launched on Stem Cell Awareness Day

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News